CLASS III Drug recall · Reported 7 Oct 2015 · FDA Enforcement Report

Metoclopramide Oral Solution, USP 10 mg/ cups recalled by VistaPharm

VistaPharm is recalling Metoclopramide Oral Solution, USP 10 mg/ cups, distributed in California, Illinois, Louisiana, Ohio, Pennsylvania, South Carolina. The recall was initiated on 26 Jun 2015 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: 387500, Expiry: 01/17

Quantity recalled84,100 Cups

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number: D-1831-2015
FDA event ID: 71601
Recalling firm: VistaPharm, Largo, FL
Classification: Class III
Status: Terminated
Recall initiated: 26 Jun 2015
FDA classified: 28 Sep 2015
Reported: 7 Oct 2015
Type: Voluntary: Firm initiated
Customers notified by: E-Mail
Reason category: Other Reasons
Drug class: Stomach & Acid Reflux Medication

Timeline

26 Jun 2015	Recall initiated by company
28 Sep 2015	Classified by FDA	+94 days
7 Oct 2015	Published in enforcement report	+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Defective Container: Lids on unit dose cups are not fully qualified.

Product as listed by the FDA

METOCLOPRAMIDE ORAL SOLUTION, USP 10 mg/10 mL, 10 mL cups, Rx only. Manufactured by VistaPharm, Inc, Largo, FL. NDC: 66689-031-01.

Where it was distributed

U.S. Including: CA, IL, LA, OH, PA, and SC.

California Illinois Louisiana Ohio Pennsylvania South Carolina

Questions about this recall

Why was it recalled?

Defective Container: Lids on unit dose cups are not fully qualified.

Which lots are affected?

Lot #: 387500, Expiry: 01/17

Where was it sold?

U.S. Including: CA, IL, LA, OH, PA, and SC.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from VistaPharm

All 36

Reported	Class	Recall	Company	Reason	Where
6 Dec 2023Drug	CLASS III	Aminocaproic Acid Oral Solution/mL recalled by VistaPharm	VistaPharm	Packaging Defects	Nationwide
15 Nov 2023Drug	CLASS III	Mycophenolate Mofetil for Oral Suspension, USP, 200 mg/mL recalled	VistaPharm	Other	Nationwide
25 Oct 2023Drug	CLASS I	Sucralfate Oral Suspension per PET bottle) recalled by VistaPharmSucralfate	VistaPharm	Other Bacterial Contamination	Nationwide
20 Sep 2023Drug	CLASS II	Sucralfate Oral Suspension per, For Oral Administration Only bottle) recalledSucralfate	VistaPharm	Potency & Assay	Nationwide
2 Nov 2022Drug	CLASS II	Pyridostigmine Bromide Oral Solution, USP 60 mg/ Delivers recalledPyridostigmine Bromide	VistaPharm	Potency & Assay	Nationwide

Other Metoclopramide recalls

All 14

Reported	Class	Recall	Company	Reason	Where
21 Oct 2026Drug	CLASS II	Metoclopramide Tablets, USP, 5 mg (10 recalledMetoclopramide	American Health Packaging	Packaging Defects	Nationwide
21 Oct 2026Drug	CLASS II	Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets recalledMetoclopramide	Teva Pharmaceuticals USA	Other	Nationwide
2 Jul 2025Drug	CLASS II	Metoclopramide Tablets, USP 10 mg recalled by Teva Pharmaceuticals USAMetoclopramide	Teva Pharmaceuticals USA	Other	Nationwide
25 Aug 2021Drug	CLASS II	Metoclopramide Injection USP, 10 mg/ (5 mg/mL) single-use vial recalledMetoclopramide	Teva Pharmaceuticals USA	Sterility	Nationwide
26 May 2021Drug	CLASS II	Metoclopramide Injection USP, 10 mg/ (5 mg/mL) Single-Use Vial recalledMetoclopramide	Teva Pharmaceuticals USA	Sterility	Nationwide